Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
Combining Dynamic Biosensors’ Innovative Technologies with Bruker’s High-Performance SPR Portfolio to Establish a Leading Biosensors Business
Bruker Corporation announced the acquisition of Dynamic biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker’s biophysical portfolio for the analysis of Molecular Interactions and kinetics, offering deeper insights into both inter-molecular and molecule-single cell interactions in drug discovery or basic research.
Dynamic Biosensors (DBS) develops and markets innovative technologies for studying complex molecular interactions and kinetics, supporting drug discovery in the pharma and biotech industries, as well as in basic and medical research. The new Dynamic Biosensors heli X cyto instrument performs single-cell Interaction Cytometry (scIC) for kinetic measurements directly on cells, retaining the molecules’ native membrane environment. The heli X + instrument utilizes switch SENSE ® technology, employing DNA nanolevers to functionalize molecules of interest on the chip surface to characterize their binding behavior and kinetics, as well as conformational changes. In combination with Bruker’s high-throughput Surface Plasmon Resonance (SPR) portfolio, which includes the all-new SPR #64 ‘Triceratops’ , and the 24- and 32-spot Sierra-Pro SPR systems, the combined Bruker Biosensors business now offers one of the most innovative range of instruments, workflows, and consumables for studying inter-molecular and molecule-cell interactions in the drug discovery pipeline.
Financial details of the transaction were not disclosed. In FY2025, Bruker Biosensors expects additional revenues greater than $5 million from the DBS acquisition, with no material EPS impact.
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Unlike rubber bands, molecular bonds may not break faster when pulled
Machine learning reveals the mysteries of thin films at atomic scale - High-accuracy atomistic modeling of amorphous materials
First-ever X-ray attosecond experiment on liquids provides new insights into water’s molecular properties - Theorists explain how X-ray measurement freezes hydrogen motion, with implications on other areas of chemistry
New tagging technique enhances view of living cells
Out-sniffing bomb-sniffing dogs - Tel Aviv University researcher leads development of swift, small, highly reliable sensor to detect explosives
Imperial and Tsinghua University launch seed fund for 'ambitious collaborations'
'Lab on a chip' mimics brain chemistry
3D internal structure of rechargeable batteries revealed for the first time
Scientists accelerate spectroscopic analysis - "This innovation expands the application of compressed sensing to real-time spectroscopic measurement"
PolyIC, BASF, Evonik Industries, Elantas Beck and Siemens form alliance project for printed electronics - Radio frequency identification tags: the next generation
MRI findings shed light on multiple sclerosis